EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Population pharmacokinetic modeling of paired plasma–breast milk lamivudine data for estimation of infant exposure in breastfeeding mother–infant pairs

Francis Williams Ojara iD, Aida N Kawuma iD, Shadia Nakalema iD, Isabella Kyohairwe iD, Ritah Nakijoba iD, Mohammed Lamorde iD, Henry Pertinez, Saye Khoo iD, Catriona Waitt iD

CPT: Pharmacometrics & Systems Pharmacology · 2024

DOI: 10.1002/psp4.13274 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2024. Verfasst von Francis Williams Ojara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Milk, Human, Lamivudine, Breast Feeding, Models, Biological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Around 1.2 million women living with HIV give birth annually, majority of whom will breastfeed their infants while receiving antiretroviral therapy (ART). Lamivudine, a component of first‐line ART regimens crosses from maternal plasma to breast milk, with measurable concentrations in some breastfed infants. Wide variability in plasma‐to‐breast milk transfer has been reported within‐ or across studies, probably due to differences in sampling framework. This work sought to characterize the milk‐to‐plasma transfer of lamivudine, quantify inter‐patient variability and associated factors, and predict exposure of a breastfed infant. We explored data from an observational pharmacokinetic study that included 35 Ugandan mothers and their infants. Mothers received lamivudine doses of 150 mg twice daily or 300 mg once daily as part of their antiretroviral regimen. Pharmacokinetic sampling was undertaken across two visits approximately 8 weeks apart, providing 248 maternal plasma, 256 breast milk‐, and 151 infant blood concentrations, measured across a 24‐h sampling interval. A one‐compartmental model best described the plasma disposition of lamivudine, with first‐order absorption, interindividual variability on clearance and volume of distribution, and a proportional residual error model. A lag in time of plasma‐to‐breast milk drug accumulation was described using an effect compartment model with a milk‐to‐plasma ratio of 1.77. An estimated daily infant dose of 179.3 μg/kg (range: 125.8, 282.3) closely predicted the observed infant steady‐state concentrations and translated into 3.34% (2.13, 7.20) and 3.35% (1.10, 7.15) of the standard daily maternal dose in visits 1 and 2, respectively. The established modeling framework can be extended to other drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Milk, HumanLamivudineBreast FeedingModels, BiologicalHIV InfectionsAnti-HIV AgentsHumansFemaleInfantAdultUgandaInfant, NewbornYoung AdultMale

Substanzen

LamivudineAnti-HIV Agents

Autor:innen und Institutionen

  • Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Department of Pharmacology and Therapeutics, Gulu University, Gulu, Uganda.
  • Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.

ORCID-Profile: Francis Williams Ojara, Aida N Kawuma, Shadia Nakalema, Isabella Kyohairwe, Ritah Nakijoba, Mohammed Lamorde, Saye Khoo, Catriona Waitt

Zitieren

APA

Ojara, F. W., Kawuma, A. N., Nakalema, S., Kyohairwe, I., Nakijoba, R., Lamorde, M., Pertinez, H., Khoo, S., & Waitt, C. (2024). Population pharmacokinetic modeling of paired plasma–breast milk lamivudine data for estimation of infant exposure in breastfeeding mother–infant pairs. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13274

Vancouver

Ojara FW, Kawuma AN, Nakalema S, Kyohairwe I, Nakijoba R, Lamorde M, et al. Population pharmacokinetic modeling of paired plasma–breast milk lamivudine data for estimation of infant exposure in breastfeeding mother–infant pairs. CPT: Pharmacometrics & Systems Pharmacology. 2024. doi:10.1002/psp4.13274

BibTeX
@article{Ojara2024,
  author = {Ojara, Francis Williams and Kawuma, Aida N and Nakalema, Shadia and Kyohairwe, Isabella and Nakijoba, Ritah and Lamorde, Mohammed and Pertinez, Henry and Khoo, Saye and Waitt, Catriona},
  title = {Population pharmacokinetic modeling of paired plasma–breast milk lamivudine data for estimation of infant exposure in breastfeeding mother–infant pairs},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2024},
  doi = {10.1002/psp4.13274}
}
Kostenlos starten →